2.1. Study Population
NSTEMI, STEMI
DISEASE, DISEASES
This was a single-center, prospective, randomized, open-label clinical trial consecutively screening patients with ACS for MV disease. The study population included patients with sinus rhythm only, to precisely measure left chamber segmental myocardial deformation and peak mechanical dispersion. Simple randomization method has been used without cross-over between groups. Seventeen patients were initially enrolled in this study and completed the 3-month follow-up during the period of two years (2020–2021). Trial performed in Cardiology and internal diseases center of Daugavpils Regional Hospital, Latvia. First round patient selection was performed by intensive care unit and emergency department clinicians. Where NSTEMI patients received echocardiography prior to the acute coronary angiography. And STEMI patients received echocardiographic evaluation in the first 24 h after acute coronary angiography to re-check for exclusion criteria.